Brief: Invivyd Inc - Remain On Track To Have Initial Primary Endpoint Data Around Year End

Invivyd

11/09/2023 12:28

Invivyd Inc  IVVD.O :
    * INVIVYD ANNOUNCES DOSING OF FIRST PARTICIPANT IN CANOPY
PHASE 3
PIVOTAL CLINICAL TRIAL INVESTIGATING VYD222 FOR THE PREVENTION
OF SYMPTOMATIC COVID-19
    * INVIVYD INC - REMAIN ON TRACK TO HAVE INITIAL PRIMARY
ENDPOINT
DATA AROUND YEAR END

Source text for Eikon:  ID:nGNXhHy61 
Further company coverage:  IVVD.O